{"id":"nasal-fluticasone","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Epistaxis (nosebleed)"},{"rate":"3-8","effect":"Nasal irritation"},{"rate":"2-5","effect":"Headache"},{"rate":"1-3","effect":"Pharyngitis"},{"rate":"1-2","effect":"Cough"}]},"_chembl":null,"_dailymed":{"setId":"cf2e16be-0126-412e-9ddd-013f97a7a742","title":"FLUTICASONE PROPIONATE NASAL (FLUTICASONE PROPIONATE) SPRAY, METERED [CVS PHARMACY]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluticasone propionate binds to glucocorticoid receptors in nasal tissue, inhibiting the production of pro-inflammatory cytokines and chemokines. This reduces swelling, mucus production, and allergic/inflammatory responses in the nasal cavity. When administered as a nasal spray, it provides local anti-inflammatory effects with minimal systemic absorption.","oneSentence":"Fluticasone is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:42.190Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Nasal polyps"},{"name":"Chronic rhinosinusitis"}]},"trialDetails":[{"nctId":"NCT06850805","phase":"PHASE3","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2025-07-28","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":84},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT07415278","phase":"PHASE4","title":"INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pamukkale University","startDate":"2022-12-01","conditions":"Allergic Rhinitis","enrollment":61},{"nctId":"NCT07294326","phase":"PHASE4","title":"A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Union Hospital","startDate":"2026-01-01","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT05299086","phase":"PHASE3","title":"As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2022-04-04","conditions":"Perennial Allergic Rhinitis, Child, Only","enrollment":68},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT06858423","phase":"PHASE4","title":"Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-08-15","conditions":"Nasal Allergy","enrollment":360},{"nctId":"NCT02630121","phase":"PHASE4","title":"Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea","status":"RECRUITING","sponsor":"University of South Florida","startDate":"2023-04-01","conditions":"Sleep Apnea, Chronic Nasal Congestion","enrollment":52},{"nctId":"NCT06323304","phase":"NA","title":"Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2024-03-13","conditions":"Itching, Runny Nose, Sneezing","enrollment":90},{"nctId":"NCT02402465","phase":"PHASE4","title":"Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02","conditions":"Allergic Rhinitis","enrollment":22},{"nctId":"NCT05192499","phase":"NA","title":"Respiratory Dysbiosis in Preschool Children with Asthma: Predictive of a Severe Form","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2022-02-04","conditions":"Asthma in Children, Dysbiosis","enrollment":30},{"nctId":"NCT00817050","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00783458","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT03364959","phase":"NA","title":"Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old","status":"TERMINATED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-10-23","conditions":"Asthma in Children","enrollment":60},{"nctId":"NCT05080322","phase":"PHASE4","title":"Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis","status":"RECRUITING","sponsor":"Zheng Liu ENT","startDate":"2021-09-09","conditions":"Allergic Rhinitis","enrollment":150},{"nctId":"NCT06180083","phase":"PHASE1","title":"Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2023-03-24","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":56},{"nctId":"NCT05158972","phase":"","title":"Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2021-10-27","conditions":"Allergic Rhinitis","enrollment":924},{"nctId":"NCT04601324","phase":"PHASE4","title":"Allergic Rhinitis Combination Pharmacotherapy Efficacy Study","status":"WITHDRAWN","sponsor":"St. Paul's Sinus Centre","startDate":"2020-12-15","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT06051786","phase":"PHASE2","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Synmosa Biopharma Corp.","startDate":"2020-08-20","conditions":"Allergic Rhinitis","enrollment":136},{"nctId":"NCT02246920","phase":"PHASE3","title":"Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients","status":"TERMINATED","sponsor":"Teva Pharmaceuticals USA","startDate":"2014-03-01","conditions":"Seasonal Allergic Rhinitis","enrollment":1474},{"nctId":"NCT04171167","phase":"NA","title":"The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tampere University Hospital","startDate":"2017-04-04","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":88},{"nctId":"NCT04652245","phase":"PHASE4","title":"Dymista Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2020-12-14","conditions":"Seasonal Allergic Rhinitis","enrollment":216},{"nctId":"NCT05651750","phase":"PHASE4","title":"Medical vs Surgical Treatment in OSA Among Children","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2022-11-15","conditions":"To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results","enrollment":90},{"nctId":"NCT05314621","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-31","conditions":"Allergic Conjunctivitis","enrollment":61},{"nctId":"NCT02874144","phase":"PHASE2","title":"Anti-Inflammatory Agent in Sinusitis","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-06-20","conditions":"Nasal Polyps","enrollment":43},{"nctId":"NCT05381207","phase":"EARLY_PHASE1","title":"Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-10","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT03317015","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-30","conditions":"Rhinitis Allergic","enrollment":260},{"nctId":"NCT05143502","phase":"PHASE1, PHASE2","title":"Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-01-01","conditions":"Montelukast, Chronic Rhinosinusitis With Nasal Polyps","enrollment":60},{"nctId":"NCT03599791","phase":"PHASE3","title":"DYmista NAsal Spray in CHInese Patients","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2018-06-29","conditions":"Allergic Rhinitis","enrollment":900},{"nctId":"NCT03004131","phase":"PHASE4","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2017-01-07","conditions":"Seasonal Allergic Rhinitis","enrollment":82},{"nctId":"NCT03882047","phase":"PHASE3","title":"Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-08-11","conditions":"Rhinitis, Allergic, Seasonal","enrollment":313},{"nctId":"NCT00783224","phase":"PHASE3","title":"A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Perennial Allergic Rhinitis","enrollment":351},{"nctId":"NCT01190852","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01194622","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT02180672","phase":"PHASE3","title":"Steroids for Pediatric Apnea Research in Kids","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2014-09","conditions":"Obstructive Sleep Apnea Syndrome","enrollment":211},{"nctId":"NCT02230696","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":951},{"nctId":"NCT04179461","phase":"PHASE2","title":"Personalized Treatment Algorithms for Difficult-to-treat Asthma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-03-16","conditions":"Asthma in Children","enrollment":21},{"nctId":"NCT02883439","phase":"NA","title":"Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate","status":"WITHDRAWN","sponsor":"University Hospital, Ghent","startDate":"2016-08","conditions":"Bioavailability Study","enrollment":""},{"nctId":"NCT01439815","phase":"PHASE4","title":"An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2011-09","conditions":"Allergic Rhinitis, Allergic Conjunctivitis","enrollment":22},{"nctId":"NCT04242368","phase":"PHASE2, PHASE3","title":"Hypertonic Versus Isotonic Saline Irrigations for Chronic Rhinosinusitis","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2020-07-01","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":""},{"nctId":"NCT04752956","phase":"NA","title":"Effectiveness of Sodium Hyaluronate In Relieving Nasal Symptoms Of Children With Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Saglik Bilimleri Universitesi","startDate":"2019-03-03","conditions":"Seasonal Allergic Rhinitis","enrollment":101},{"nctId":"NCT01279057","phase":"PHASE3","title":"A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sandoz","startDate":"2010-12-27","conditions":"Rhinitis, Allergic, Seasonal","enrollment":727},{"nctId":"NCT02424539","phase":"PHASE4","title":"A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-09-30","conditions":"Rhinitis, Allergic, Perennial and Seasonal, Rhinitis, Allergic","enrollment":358},{"nctId":"NCT01578278","phase":"PHASE2","title":"Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2011-12","conditions":"Seasonal Allergic Rhinitis","enrollment":606},{"nctId":"NCT03591068","phase":"PHASE3","title":"Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2018-06-07","conditions":"Nasal Polyposis","enrollment":11},{"nctId":"NCT03884114","phase":"NA","title":"Comparison of Three Modalities to Assess Clinical Competence of Medical Students","status":"COMPLETED","sponsor":"Ilumens","startDate":"2019-03-20","conditions":"Educational Problems","enrollment":42},{"nctId":"NCT02885025","phase":"PHASE2","title":"Effects of Broccoli Sprout Extract on Allergy Rhinitis","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2016-10-01","conditions":"Rhinitis,Allergic","enrollment":47},{"nctId":"NCT04332978","phase":"PHASE3","title":"Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene","status":"COMPLETED","sponsor":"Libbs Farmacêutica LTDA","startDate":"2014-07-04","conditions":"Perennial Allergic Rhinitis","enrollment":566},{"nctId":"NCT03443843","phase":"PHASE4","title":"A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-02-21","conditions":"Rhinitis, Allergic","enrollment":82},{"nctId":"NCT00903227","phase":"PHASE4","title":"Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2006-12","conditions":"Asthma, Allergic Rhinitis","enrollment":25},{"nctId":"NCT01388595","phase":"PHASE4","title":"Fluticasone and Salmeterol in Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2006-11","conditions":"Allergic Rhinitis","enrollment":23},{"nctId":"NCT03594565","phase":"EARLY_PHASE1","title":"The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2016-03","conditions":"T1DM, Hypersensitivity","enrollment":13},{"nctId":"NCT02856282","phase":"","title":"Drug Utilization Study for Pirinase Hayfever Relief","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-02-15","conditions":"Rhinitis, Allergic, Seasonal","enrollment":46},{"nctId":"NCT02953106","phase":"PHASE4","title":"Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2017-01-20","conditions":"Asthma, Allergic, Rhinitis,Allergic, Allergy","enrollment":7},{"nctId":"NCT01622569","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2013-11-19","conditions":"Bilateral Nasal Polyposis","enrollment":323},{"nctId":"NCT01624662","phase":"PHASE3","title":"Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2013-10-30","conditions":"Bilateral Nasal Polyposis","enrollment":323},{"nctId":"NCT02182492","phase":"NA","title":"Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"Zheng Liu","startDate":"2014-01","conditions":"Chronic Rhinosinusitis, Endoscopic Sinus Surgery","enrollment":187},{"nctId":"NCT03673384","phase":"NA","title":"Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation","status":"COMPLETED","sponsor":"Nanhua University","startDate":"2015-03-02","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT00363740","phase":"PHASE3","title":"Study of GW685698X In Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02-19","conditions":"Rhinitis, Allergic, Seasonal","enrollment":38},{"nctId":"NCT01916226","phase":"PHASE4","title":"A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-01","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":682},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT00997620","phase":"PHASE4","title":"Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Western Sky Medical Research","startDate":"2010-03","conditions":"Seasonal Allergic Rhinitis","enrollment":40},{"nctId":"NCT00289198","phase":"PHASE3","title":"Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-02-07","conditions":"Rhinitis, Allergic, Perennial","enrollment":301},{"nctId":"NCT00435461","phase":"PHASE4","title":"Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1000},{"nctId":"NCT00398476","phase":"PHASE3","title":"Fluticasone Nasal Spray Patient Preference Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":127},{"nctId":"NCT03449836","phase":"PHASE3","title":"Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2018-03-01","conditions":"Allergy","enrollment":60},{"nctId":"NCT02194062","phase":"NA","title":"Comparison of Nasal Steroids After FESS in CRSwNP","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-01","conditions":"Sinusitis, Nasal Polyps","enrollment":32},{"nctId":"NCT01623310","phase":"PHASE3","title":"12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2013-09","conditions":"Nasal Polyps","enrollment":223},{"nctId":"NCT00400998","phase":"PHASE2","title":"Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Research Consult GmbH","startDate":"2006-03","conditions":"Allergic Rhinitis, Rhinitis, Allergic, Seasonal","enrollment":41},{"nctId":"NCT02397915","phase":"PHASE4","title":"Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-03-26","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":300},{"nctId":"NCT02569437","phase":"PHASE2","title":"Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-09","conditions":"Polyp of Nasal Sinus","enrollment":49},{"nctId":"NCT00570492","phase":"PHASE4","title":"Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-11-26","conditions":"Rhinitis, Allergic, Perennial","enrollment":474},{"nctId":"NCT01013701","phase":"PHASE4","title":"Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2009-11","conditions":"Patients With Nasal Polyps","enrollment":7},{"nctId":"NCT00404586","phase":"PHASE1","title":"Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09-11","conditions":"Rhinitis, Allergic, Perennial","enrollment":45},{"nctId":"NCT01199757","phase":"","title":"A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07-10","conditions":"Rhinitis, Allergic, Perennial","enrollment":540},{"nctId":"NCT01231464","phase":"PHASE3","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-09","conditions":"Rhinitis, Allergic, Perennial, Allergic Rhinitis","enrollment":365},{"nctId":"NCT03174483","phase":"NA","title":"Radiologic Scoring of Patients With Chronic Sinusitis and Nasal Polyps","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06","conditions":"Chronic Sinusitis","enrollment":60},{"nctId":"NCT01337323","phase":"","title":"Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2010-09","conditions":"Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis","enrollment":3},{"nctId":"NCT01018030","phase":"PHASE2","title":"Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-01-06","conditions":"Sinusitis, Acute","enrollment":741},{"nctId":"NCT00730756","phase":"PHASE2","title":"A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT01777906","phase":"","title":"Study of the Efficacy of Topical Nasal Steroids Patients With Nasal Polyps","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2013-02","conditions":"Size of Nasal Polyps, Control of Symptoms","enrollment":40},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT00682643","phase":"PHASE4","title":"A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":550},{"nctId":"NCT00503009","phase":"PHASE4","title":"Study Of RV-39 In Patients Who Also Have Asthma","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2007-10","conditions":"Asthma","enrollment":16},{"nctId":"NCT00609674","phase":"PHASE4","title":"A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":315},{"nctId":"NCT00296491","phase":"PHASE4","title":"Study Of Allergic Rhinitis In Patients Who Also Have Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09","conditions":"Asthma","enrollment":725},{"nctId":"NCT00502775","phase":"PHASE4","title":"Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Seasonal","enrollment":680},{"nctId":"NCT00539006","phase":"PHASE4","title":"Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":377},{"nctId":"NCT00519636","phase":"PHASE4","title":"Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":360},{"nctId":"NCT00163488","phase":"PHASE3","title":"Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-01","conditions":"Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever","enrollment":106},{"nctId":"NCT00296530","phase":"PHASE4","title":"Study Of Patients With Allergic Rhinitis And Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09","conditions":"Asthma","enrollment":600},{"nctId":"NCT00846326","phase":"PHASE4","title":"Preventing Tolerance to Oxymetazoline in Allergic Rhinitis","status":"WITHDRAWN","sponsor":"Brian J Lipworth","startDate":"","conditions":"Allergic Rhinitis, Tachyphylaxis, Rhinitis Medicamentosa","enrollment":""},{"nctId":"NCT00109486","phase":"PHASE3","title":"Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-04","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":56},{"nctId":"NCT00116818","phase":"PHASE3","title":"A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":90},{"nctId":"NCT00115622","phase":"PHASE3","title":"Study In Adults And Adolescents With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-12","conditions":"Hayfever, Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis","enrollment":304},{"nctId":"NCT01562093","phase":"NA","title":"Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2012-01","conditions":"Asthma","enrollment":14},{"nctId":"NCT01623323","phase":"PHASE3","title":"Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2013-09","conditions":"Chronic Sinusitis With or Without Nasal Polyps","enrollment":705},{"nctId":"NCT00385463","phase":"NA","title":"Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo","status":"WITHDRAWN","sponsor":"Creighton University","startDate":"2006-04","conditions":"Asthma, Seasonal Allergic Rhinitis","enrollment":""},{"nctId":"NCT02266927","phase":"PHASE1","title":"A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)","status":"COMPLETED","sponsor":"Optinose US Inc.","startDate":"2014-09","conditions":"Mild to Moderate Asthma","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NCS","Nasal steroids","Nasal corticosteroids"],"phase":"marketed","status":"active","brandName":"Nasal Fluticasone","genericName":"Nasal Fluticasone","companyName":"Children's Hospital of Philadelphia","companyId":"children-s-hospital-of-philadelphia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nasal Fluticasone is a small molecule glucocorticoid receptor agonist used to treat various conditions, including perennial and seasonal allergic rhinitis, and allergic rhinitis. It is administered as a nasal spray and belongs to the drug class of glucocorticoid receptor agonists.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}